Review Duration and Therapeutic Value of Cancer Drugs Granted Priority Versus Nonpriority Review in the United States, European Union, and Switzerland (2010-2024)
Year: 2026
Type: article
Source: JCO Oncology Practice
DOI: 10.1200/op-25-01270
Institutions: University of Zurich, ETH Zurich, Swissmedic
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W7147580563